Efficacy and safety of a once-daily fixed-dose combination of abacavir/lamivudine compared with abacavir twice daily and lamivudine once daily as separate entities in antiretroviral experienced HIV-1 infected patients (CAL30001 Study) Academic Article 2006 uri icon

authors

  • LaMarca A
  • Scott T
  • the CAL30001 Sudy Team
  • GUTIERREZ RODERO, FELIX
  • Clumeck N
  • Pletenberg A
  • Domingo P
  • Fu K
  • Craig C
  • Zhao H
  • Watson M
  • Gordon D

publication date

  • 2006